Pharmaceutical Industry - Publications - Faculty & Research

December 2002
Teaching Note

Abgenix and the XenoMouse (TN)

Teaching Note for (501-061). View Details

Keywords: Health Testing and Trials; Decision Choices and Conditions; Sales; Product Development; Joint Ventures; Health Industry; Health Industry

Citation

Purchase

May 2002 (Revised December 2003)
Teaching Note

Medicines Company, The TN

By: John T. Gourville

Teaching Note for (9-502-006). View Details

Keywords: Pharmaceutical Industry; Pharmaceutical Industry

Citation

Purchase

August 2001 (Revised March 2008)
Case

Helios Health (A)

By: Regina E. Herzlinger and Alfred Martin

Helios PC system provides personalized drug information to the patients in the doctor's waiting room. It has met with considerable consumer acceptance and a very high return for the drug companies that sponsor it. What price should it charge them for the service? View Details

Keywords: Entrepreneurship; Price; Health Care and Treatment; Information Publishing; Innovation and Invention; Product Marketing; Demand and Consumers; Health Industry; Health Industry

Citation

Find at Harvard

March 1995 (Revised January 1996)
Teaching Note

Portfolio Planning at Ciba-Geigy and the Newport Investment Proposal TN

By: David J. Collis

Teaching Note for (9-795-040). View Details

Keywords: Chemical Industry; Chemical Industry; Switzerland

Citation

Purchase

2007
Chapter

Fighting AIDS, Fighting Poverty: Customer Centric Marketing in the Generic Antiretroviral Business

By: Rohit Deshpandé and Zoe Chance

Keywords: Health Disorders; Poverty; Product Marketing; Customers; Pharmaceutical Industry; Pharmaceutical Industry

Citation

September 1990 (Revised March 1991)
Supplement

RU 486 (B)

By: Joseph L. Badaracco Jr.

Describes how Roussel UCLAF resolved the dilemma. Intended for use as an in-class handout. View Details

Keywords: Pharmaceutical Industry; Pharmaceutical Industry; France; Germany; United States

Citation

Purchase

01 Mar 2003
News

Naina Lal Kidwai

to the global automobile industry. Biotechnology and pharmaceutical firms are emerging as international players. There are also opportunities in infrastructure investment, such as telecom, ports, roads, and airports. Please comment on... View Details

Keywords: Garry Emmons; Funds, Trusts, and Other Financial Vehicles; Finance

21 Nov 2006
First Look

First Look: November 21, 2006

cost to identify and investigate. The Effect of File Sharing on Record Sales: An Empirical Analysis Authors:Felix Oberholzer-Gee and Koleman Strumpf Periodical:Journal of Political Economy (forthcoming) Abstract For industries ranging... View Details

Keywords: Sean Silverthorne

23 Mar 2010
First Look

First Look: March 23

catastrophic risks to patients, physicians, pharmaceutical firms, and regulators. Between the early 1960s and the present, national systems were built to collect, standardize, and respond to individual reports of side effects, with the... View Details

Keywords: Martha Lagace

16 Jun 2015
First Look

First Look: June 16, 2015

particularly in the vaccine space, had begun to attract the attention of much larger pharmaceutical companies. While there was much appeal to working with these companies, these relationships could also challenge Crucell's independence.... View Details

Keywords: Sean Silverthorne

12 May 2009
First Look

First Look: May 12, 2009

illustrates how deep dives guide the formation of a set of new core activities in the variation-selection-retention process. No PDF is available at this time. PublicationsWhat Causes Industry Agglomeration? Evidence from Coagglomeration... View Details

Keywords: Martha Lagace

09 Feb 2016
First Look

February 9, 2016

challenges as it seeks to continue its growth. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/816013-PDF-ENG Harvard Business School Case 316-010 The Allergan Board Under Fire (A) In 2014, the Allergan Inc. board of directors received a surprise takeover... View Details

Keywords: Sean Silverthorne

03 Jan 2007
First Look

First Look: January 3, 2007

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=207077 Framedia Harvard Business School Case 207-057 Examines an acquisition in the highly competitive new media advertising industry in China in late 2005. The transaction... View Details

Keywords: Sean Silverthorne

06 Jun 2017
First Look

First Look at New Research and Ideas: June 6, 2017

modern industrial corporation encompasses a myriad of different software applications, which must work in concert to deliver functionality to end users. However, the increasingly complex and dynamic nature of competition in today’s... View Details

Keywords: Sean Silverthorne

01 Feb 2000
News

Executives Convene to Discuss Consumer-Driven Health Care

available to their workers. The conference's agenda alternated between small breakout sessions that brought together participants from different industry areas and large group discussions where all attendees could compare notes. The... View Details

Web

Souvenirs & Novelties - The Art of American Advertising

distribute them and local retailers to print their names on them at no cost. James C. Ayer, involved in the pharmaceutical industry, reaped enormous publicity benefits from the distribution of yearly almanacs. Ayer eventually established... View Details

March 2025
Teaching Note

Gavi and the 'Next' Pandemic

By: Tarun Khanna and Samir Junnarkar

Teaching Note for HBS Case No. 725-351. View Details

Keywords: Pharmaceutical Industry; Africa

Citation

Purchase

August 2024
Article

How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?

By: Leemore S. Dafny, Kate Ho and Edward Kong

Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name prescription drugs. Medicare bans such coupons on the grounds that they are kickbacks that induce utilization, but they are commonly used by... View Details

Keywords: Prescription Drugs; Coupons; Impact; Health Care and Treatment; Markets; Price; Spending; Pharmaceutical Industry; United States

Citation

Find at Harvard

Register to Read

Forthcoming
Article

Regulatory Incentives for Innovation: The FDA's Breakthrough Therapy Designation

By: Amitabh Chandra, Jennifer Kao, Kathleen L. Miller and Ariel Dora Stern

Regulators of new products confront a tradeoff between speeding a product to market and collecting additional product quality information. The FDA's Breakthrough Therapy Designation (BTD) provides an opportunity to understand if regulators can use new policy to... View Details

Keywords: Innovation and Invention; Governing Rules, Regulations, and Reforms; Government Administration; Research and Development; Pharmaceutical Industry

Citation

Find at Harvard

Register to Read